Skip to main content

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Remarkable Science
Changes Everything

Aesthetics Pipeline

Revance will initially address Glabellar (frown) lines, one of the single greatest demands within the facial aesthetics category.
 

View Product Pipeline >>

Therapeutics Pipeline

Therapeutic indications for botulinum toxin represent more than half of the estimated $3.4 billion global neurotoxin market.
 

View Product Pipeline >>

Stock Quote

17.52  -0.33 (-1.85%)

NASDAQ: RVNC - Sep 23, 4:00PM EDT
 

Learn More >>

DaxibotulinumtoxinA for Injection (RT002)

With investigational product candidate RT002 injectable, daxibotulinumtoxinA may result in an extended duration of response.
 

Learn More >>

TransMTS® Peptide Companion Technology

TransMTS is a unique peptide excipient, that when combined with active drug, shows potential to address current unmet needs in both aesthetic medicine and therapeutic specialties.
 

Learn More >>

RT002 injectable and RT001 topical are investigational product candidates. RT002 is currently undergoing clinical studies for both therapeutic and aesthetic indications. RT001 is in preclinical development.